Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
SAP
SAP
$248B
| $844M | 0.04% |
5,476,111
+1,860,094
| +51% | +$317M |
2013 Q2
52 quarters
|
|
377
First Trust Value Line Dividend Fund
FVD
$7.68B
| $843M | 0.04% |
17,493,310
-654,401
| -4% | -$31.2M |
2013 Q2
52 quarters
|
|
378
Shell
SHEL
$285B
| $836M | 0.04% |
10,779,129
+1,105,213
| +11% | +$95.4M |
2022 Q1
17 quarters
|
|
379
iShares Russell 1000 ETF
IWB
$49.5B
| $836M | 0.04% |
2,040,874
+11,089
| +0.5% | +$4.39M |
2013 Q2
52 quarters
|
|
380
Alerian MLP ETF
AMLP
$12.6B
| $833M | 0.04% |
16,070,257
+234,296
| +1% | +$12.3M |
2013 Q2
52 quarters
|
|
381
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
| $832M | 0.04% |
8,705,431
-283,293
| -3% | -$26.8M |
2013 Q2
52 quarters
|
|
382
Steris
STE
$20.9B
| $832M | 0.04% |
3,950,067
-444,196
| -10% | -$95.2M |
2013 Q2
52 quarters
|
|
383
KKR & Co
KKR
$81.6B
| $826M | 0.04% |
9,004,913
+531,260
| +6% | +$51.5M |
2013 Q2
52 quarters
|
|
384
State Street Communication Services Select Sector SPDR ETF
XLC
$23B
| $826M | 0.04% |
7,712,820
+13,704
| +0.2% | +$1.56M |
2018 Q2
32 quarters
|
|
385
Verisk Analytics
VRSK
$23.1B
| $826M | 0.04% |
4,600,861
-88,277
| -2% | -$15.5M |
2013 Q2
52 quarters
|
|
386
Royal Bank of Canada
RY
$266B
| $825M | 0.04% |
3,985,000
-1,204,064
| -23% | -$223M |
2013 Q2
52 quarters
|
|
387
Nike
NKE
$51.6B
| $824M | 0.04% |
20,078,560
-1,959,143
| -9% | -$86.2M |
2013 Q2
52 quarters
|
|
388
CRH
CRH
$54.2B
| $823M | 0.04% |
7,693,822
-1,243,669
| -14% | -$137M |
2013 Q2
52 quarters
|
|
389
Norfolk Southern
NSC
$71.4B
| $822M | 0.04% |
2,611,985
-15,435
| -0.6% | -$4.76M |
2013 Q2
52 quarters
|
|
390
Global X MLP & Energy Infrastructure ETF
MLPX
$3.52B
| $819M | 0.04% |
11,112,678
+321,443
| +3% | +$23.6M |
2013 Q4
50 quarters
|
|
391
Enterprise Products Partners
EPD
$77.9B
| $818M | 0.04% |
22,249,198
+829,676
| +4% | +$31.3M |
2013 Q2
52 quarters
|
|
392
First Trust Enhanced Short Maturity ETF
FTSM
$6.62B
| $816M | 0.04% |
13,667,911
-532,963
| -4% | -$31.9M |
2014 Q4
46 quarters
|
|
393
Astera Labs
ALAB
$59.4B
| $815M | 0.04% |
1,686,491
-45,857
| -3% | -$12.2M |
2024 Q1
9 quarters
|
|
|
B
394
Barrick Mining
B
$67.6B
| $813M | 0.04% |
22,129,526
-1,302,388
| -6% | -$53.4M |
2013 Q2
52 quarters
|
|
395
Jabil
JBL
$32.1B
| $812M | 0.04% |
2,106,748
+226,743
| +12% | +$78.3M |
2013 Q2
52 quarters
|
|
396
Strategy Inc
MSTR
$61.5B
| $811M | 0.04% |
9,330,454
+44,440
| +0.5% | +$6.45M |
2013 Q2
52 quarters
|
|
397
Microchip Technology
MCHP
$41B
| $810M | 0.04% |
8,882,961
+30,282
| +0.3% | +$2.7M |
2013 Q2
52 quarters
|
|
398
Boston Scientific
BSX
$61.9B
| $809M | 0.04% |
18,947,147
-3,319,517
| -15% | -$180M |
2013 Q2
52 quarters
|
|
399
State Street Consumer Staples Select Sector SPDR ETF
XLP
$13.7B
| $806M | 0.04% |
9,702,454
-622,338
| -6% | -$52M |
2013 Q2
52 quarters
|
|
400
Carrier Global
CARR
$45.8B
| $804M | 0.04% |
10,957,072
-1,304,143
| -11% | -$85.2M |
2020 Q2
24 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.